A groundbreaking clinical milestone has been reached with the successful long-term deployment of an implanted brain-computer interface (BCI) in a person with severe amyotrophic lateral sclerosis. Over 24 months of independent home use, the patient achieved sustained communication restoration and computer cursor control without requiring continuous researcher support—a critical advancement for translating neurotechnology from laboratory settings to real-world clinical practice.
The automated BCI system maintained consistent performance throughout the study period, with speech decoding accuracy reaching 94.7% and cursor control accuracy at 98.2%. This represents a fundamental shift in how researchers view the potential for BCIs to provide lasting therapeutic benefit. The elimination of researcher-dependent calibration addresses one of the most significant barriers to widespread clinical adoption of these devices.
The findings, published in Nature Medicine in June 2026, establish a new standard for evaluating BCI feasibility in severely paralyzed patients and open pathways for regulatory approval and patient access. Read the full article on GMJ Newsroom.
Was this article helpful?
